【君实生物:全资子公司拓普艾莱与LEO Pharma A/S签署分销与商业化协议】 君实生物公告,近日全资子公司拓普艾莱与LEO Pharma A/S签署了《分销与商业化协议》。根据协议,拓普艾莱将授予利奥制药在欧盟和欧洲经济区所有现有成员国和任何未来成员国以及瑞士、英国内储存、分销、推广、营销和销售特瑞普利单抗的独占权利。利奥制药将向拓普艾莱支付1500万欧元首付款,并支付特瑞普利单抗在合作区域内销售净额两位数百分比的销售分成。本次交易未构成关联交易,亦不构成重大资产重组。

金融界
20 Jan
君实生物公告,近日全资子公司拓普艾莱与LEO Pharma A/S签署了《分销与商业化协议》。根据协议,拓普艾莱将授予利奥制药在欧盟和欧洲经济区所有现有成员国和任何未来成员国以及瑞士、英国内储存、分销、推广、营销和销售特瑞普利单抗的独占权利。利奥制药将向拓普艾莱支付1500万欧元首付款,并支付特瑞普利单抗在合作区域内销售净额两位数百分比的销售分成。本次交易未构成关联交易,亦不构成重大资产重组。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10